TCRT
NASDAQ
$2.03
Alaunos Therapeutics Inc (TCRT)
Alaunos Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on discovering, acquiring, developing and commercializing a portfolio of immuno-oncology therapies to treat cancer patients. The company is headquartered in Houston, Texas.
Sector:
Healthcare
Industry:
Biotechnology
Target: $1.75 (-13.79%)
Market Cap
$5.07M
PEG Ratio
0.58
Free Cash Flow Yield
-63.68%
Price Chart
Valuation
Market Cap$5.07M
Forward P/E18.48
PEG0.58
P/S1689.15
P/B3.98
Profitability
Total Revenue (TTM)$3K
Gross Profit (TTM)-$1.44M
EBITDA-$4.13M
Operating Margin-138167%
EPS-$1.84
Financial Health
Free Cash Flow Yield-63.68%
Growth & Risk
EPS 5Y CAGR-49.90%
FCF 5Y CAGR-46.32%
Sharpe Ratio-0.19